Sotorasib resistance management

Sotorasib is a new anti-cancer drug used to treat KRAS gene G12C mutations in non-small cell lung cancer (NSCLC). Although the drug has shown significant efficacy in some patients, drug resistance is a common challenge in anticancer treatment. Drug resistance may cause the drug to become ineffective, allowing the patient's disease to progress again. Here are some possible treatments for sotoraxib resistance:

1. Understand the mechanisms of drug resistance: Effective treatment of drug resistance first requires an in-depth understanding of the mechanisms of drug resistance. Scientists have discovered through research that the KRAS G12C mutation may undergo multiple mutations, resulting in a reduced effect of sotoraxib. Therefore, an in-depth understanding of resistance mechanisms is crucial for targeted interventions.

2. Switch to other treatment options: Once a patient is found to be resistant to sotoraxib, doctors may consider adjusting the treatment plan. This may include switching to other anticancer drugs that target different targets to improve treatment effectiveness. The development of individualized treatment plans is critical to a patient's long-term disease management.

3. Combination therapy: Sometimes, combining sotoraxib with other anticancer drugs or treatments can be an effective strategy. Combination therapy can simultaneously intervene in cancer cells through multiple pathways and slow down the occurrence of drug resistance. This usually requires a combination of the patient's overall condition and disease characteristics.

4. Conduct clinical trials: In order to better understand the mechanisms of drug resistance and develop new treatment strategies, the medical community usually conducts clinical trials. By participating in these trials, patients have access to new drugs or treatments that are not yet on the market, and they provide scientists with the opportunity to gain insights into drug resistance.

5. Drug rotation strategy: In some cases, doctors may adopt a drug rotation strategy, that is, temporarily discontinuing sotoraxib, allowing the patient to rest for a period of time, and then restart treatment. This could help slow the progression of resistance and prolong the effectiveness of the drug.

6. Precision medicine strategy: Using precision medicine methods, such as genomics and molecular biology, we can better understand the disease characteristics of individual patients and provide guidance for personalized treatment. This approach helps tailor treatment regimens to patients' genotypic and phenotypic characteristics to maximize efficacy.

7. Comprehensive treatment team: Effective management of drug resistance requires a comprehensive treatment team, including oncologists, clinicians, molecular biologists, etc. Through collaborative cooperation, the team can jointly develop the best treatment plan and adjust the treatment strategy at any time.

Although new anti-cancer drugs such as sotoraxib have brought new hope for cancer treatment, drug resistance is a problem that cannot be ignored. In order to better deal with drug resistance, scientists and doctors need to continue to conduct in-depth research and continuously improve treatment strategies to better serve the health of cancer patients. In terms of specific treatment options, the development of personalized and precision medicine provides new directions for overcoming drug resistance.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.